StockData

Frazier Life Sciences Acquisition Corp. II (FLSC) income statement

FLSCNasdaqBlank ChecksFiscal year ends December 31
Last filing: 10-Q on Nov 17, 2026
$10.05−0.02 (-0.20%)

Close on Nov 18, 2026Market cap –P/E –Yield –

Frazier Life Sciences Acquisition Corp. II income statement

AnnualQuarterlyTTM

This company has not reported income statement data in its XBRL filings.

Ratios

Latest available, balances at Sep 30, 2026

Profitability, FY

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY
–

Financial strength

Current ratio
0.31
Debt to equity
–
Debt to assets
–
Cash to current liabilities
31.0%

Valuation

P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–

See a number that looks wrong?